106 results
8-K
EX-99.1
RGEN
Repligen Corp.
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies
8-K
EX-99.1
RGEN
Repligen Corp.
21 Feb 24
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
7:47am
is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies
8-K
EX-99.2
RGEN
Repligen Corp.
7 Dec 23
Unregistered Sales of Equity Securities
7:39am
Repligen
Repligen Corporation (NASDAQ: RGEN) is a global life sciences company that develops and commercializes highly innovative bioprocessing
8-K
EX-99.1
q4r23rbo4ubnpgi1k58
31 Oct 23
Repligen Reports Third Quarter 2023 Financial Results
7:48am
8-K
EX-99.1
j993igpbj1v3qz
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
8-K
EX-99.1
89rfa 39j5
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
EX-99.2
m48i unr1aj9e
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
EX-99.1
24i4jcdj
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
8-K
EX-99.1
omk qu13j35oxizyewe
2 Aug 23
Repligen Reports Second Quarter 2023 Financial Results
7:54am
8-K
EX-99.1
4wtl9m3i 0pgnx8gs
2 May 23
Repligen Reports First Quarter 2023 Financial Results
7:48am
8-K
EX-99.1
6dna fezsbwghi
1 Nov 22
Repligen Reports Third Quarter 2022 Financial Results
7:54am
8-K
EX-99.1
381bwik 8zc54iz
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm